Deep roots grow success.

Our leadership team brings their passion and expertise to work every day—and it shows in our ability to bring products from clinical trial to patients, with exceptional speed.

We’re focused on aggressive portfolio growth, and our team brings the requisite experience, including:

Sean Brynjelsen

Chief Executive Officer & Director

With more than 20 years in the pharmaceutical industry, Sean has developed extraordinary business acumen and particular expertise in business and product development.

More

Notable Experience

  • Executive Vice President, Business Development at Sagent Pharmaceuticals, a generic injectable company acquired by Nichi-Iko Pharmaceutical Co.
  • Senior Vice President, Global Business Development at Akorn, Inc., a pharmaceutical company specializing in ophthalmic and injectable products
  • Product development, injectable pharmaceuticals at Baxter, Abbott, and Hospira

Education

  • MBA, University of Notre Dame
  • MS, Chemistry, University of Illinois
  • BS, Chemistry, University of Illinois

James Gruber, CPA

Chief Financial Officer

James brings more than 20 years of financial and accounting experience in the life sciences industry, including pharmaceuticals, medical devices, and hospital products.

More

Notable Experience

  • Vice President, US Controller at Horizon Therapeutics, a branded pharmaceutical company where he was responsible for several areas of accounting, finance, and shared services, along with Sarbanes-Oxley compliance and the integration of several acquisitions of both public and private companies
  • Various finance and accounting roles across multiple divisions of Abbott Laboratories over 14 years within both domestic and international business units of Core Diagnostics, Pharmaceuticals (AbbVie), and Hospital Products (Hospira/Pfizer)

Education

  • MBA, Northwestern University, Kellogg School of Management
  • BS, Accounting, Indiana University

Bharathi Devarakonda, PhD

Senior Vice President, Regulatory Affairs & Technical Services

Bharathi oversees the development and regulatory activities for all of our products, bringing her significant experience in pharmaceutical product development and regulatory submissions to bear daily.

More

Notable Experience

  • Product development and regulatory affairs at Morton Grove Pharmaceuticals (acquired by Wockhardt); Akorn, Inc.; Hospira (acquired by Pfizer); Rockwell Medical, Inc.; Medefil, Inc.
  • Filed more than 80 original NDA, ANDA, and ANADA applications with the FDA
  • Significant academic research experience in formulation development and drug delivery

Education

  • PhD, Pharmaceutics, University of Louisiana— Monroe
  • MS, Pharmaceutics, Indian Institute of Technology (Banaras Hindu University)
  • BS, Pharmacy, Andhra University
  • MBA, Lake Forest Graduate School of Management

Ingrid Hoos

Senior Vice President, Regulatory Affairs

Ingrid is responsible for regulatory and medical affairs activities, applying nearly 4 decades of experience in global biomedical and pharmaceutical product development—and with regulatory agencies in the US, Europe, Canada, and Japan.

More

Notable Experience

  • Vice President, Regulatory affairs at Horizon Therapeutics
  • Regulatory affairs consultant at Vantage Consulting International, Inc.
  • Regulatory affairs at Takeda Pharmaceutical; Searle; Baxter Healthcare

Education

  • BS, Chemistry, Northeastern Illinois University
  • BS, Biology, Northeastern Illinois University

David Krempa

Senior Vice President, Business Development & Investor Relations

David is responsible for our business development, corporate strategy, and investor relations activities.

More

Notable Experience

  • Business development, Sagent Pharmaceuticals; Akorn, Inc.
  • Equity analyst at Morningstar, Inc., covering the specialty pharmaceutical industry
  • Chartered Financial Analyst (CFA)

Education

  • BS, Finance, DePaul University

Scott Grossenbach

Vice President, Sales Operations

Scott is responsible for the commercialization of our products, applying more than 20 years of experience in pharmaceutical sales and marketing, commercial operations, and supply chain.

More

Notable Experience

  • Executive Director, Sales at Akorn, Inc.
  • General Manager, SubTerra, a division of CanniMed Therapeutics

Education

  • MBA, University of Michigan
  • BS, Engineering, Michigan Technological University

Danka Radosavljevic

Vice President, Quality

Danka is responsible for implementation and oversight of Quality GxP Systems encompassing product development, manufacturing, analysis, and distribution to maintain compliance with regulatory requirements and ensure patient safety.

More

Notable Experience

  • Analytical Scientist/Project Manager at Akorn, Inc.
  • Quality Control/ Analytical Development Scientist at Morton Grove Pharmaceuticals

Education

  • BS, Earth and Environmental Science (Geochemistry), University of Illinois at Chicago

Kevin Guthrie

Executive Vice-President, Commercial Operations

Kevin began his Pharmaceutical career more than 35 years ago and has gained broad experience in all aspects of the commercial business: Sales, Training, Sales Leadership, Operations, Marketing and General Management.

More

Notable Experience

  • Vice-President of Commercial Operations at Arbor Pharmaceuticals
  • President of HealthLink Dimensions, lead the company to 5 consecutive years of Inc. 5000 fastest growing companies
  • Vice-President Commercial Operations at Solvay Pharmaceuticals
  • Director of Sales Operations at Bristol-Myers Squibb

Education

  • BS, Business Administration, Murray State University
  • INSEAD International Executive Program, France and Singapore

Intrigued?

Learn about the accomplished executives who comprise our board.